Article

jdsupra.com on 2020-04-30 18:56

SAMHSA Guidance on Substance Abuse and Outpatient Treatment Centers During COVID-19

The COVID-19 pandemic is likely to have profound impacts on people with opioid use disorder (OUD) and other drug use disorders. Generally, opioid ...

Related news

ASAMHSA publishes tobacco cessation toolkit for substance use disorder treatment programs augustafreepress.com
United States
Arizona Physician Practices Should Exercise Discretion In Continuing Elective Procedures In Clinics And Outpatient Treatment Centers jdsupra.com
California , United States , Switzerland , Arizona
Medicare Now Covers Outpatient Treatment for Opioid Addiction jdsupra.com
California , United States , Switzerland
Proposed Revisions to the SAMHSA Regulations Would Permit Non-Part 2 Providers to Reference Part 2 Treatment in Patient Records jdsupra.com
California , United States , Switzerland
CMS Issues Updated COVID-19 Infection Control Guidance for Various Inpatient and Outpatient Settings jdsupra.com
California , United States , Switzerland
Staff Releases Guidance on Confidential Treatment Applications jdsupra.com
California , United States , Switzerland
New Federal Legislation Regarding Substance-Use Disorder Treatment jdsupra.com
California , United States , Switzerland
CARES Act Surprise: Substance Use Treatment Confidentiality Law Revised jdsupra.com
California , United States , Switzerland
New California Transparency Requirements for Substance Abuse Treatment Centers jdsupra.com
California
Key COVID-19 Developments and Guidance for Ambulatory Surgery Centers jdsupra.com
California , United States , Switzerland
Proposed Mental Health Parity Guidance Focuses on Nonquantitative Treatment Limitations jdsupra.com
California , United States , Switzerland
SEC Issues Streamlined Guidance for Confidential Treatment Requests jdsupra.com
California , United States , Switzerland , Reg
The 2019 Eligibility Guidance: A Change in Tone, if Not in Substance jdsupra.com
California , United States , Switzerland
EPA Issues Guidance on Creating Generic Names for Confidential Chemical Substance Identity Reporting under TSCA jdsupra.com
California , United States , Switzerland
New Jersey Seeks Additional Applicants for Alternative Treatment Centers jdsupra.com
California , United States , Switzerland
New Federal Law Targets Referrals to Substance Abuse Treatment Providers and Labs jdsupra.com
California , United States , Switzerland
Proposed Changes Affect Privacy Protections of Patients Seeking Substance Use Disorder Treatment jdsupra.com
California , United States , Switzerland
The New Kickback Prohibition for Substance Use Disorder Treatment Facilities, Clinical Laboratories and Recovery Homes jdsupra.com
California , United States , Switzerland
What Substance Use Disorder Treatment Providers Need to Know about California’s New Patient Brokering Law jdsupra.com
United States , Switzerland , California
COVID-19 Update: OMHAS issues guidance for opioid treatment programs jdsupra.com
California , United States , Switzerland